EVOQ Bio
Company profile on P2PMarketData. EVOQ Bio is a biotechnology company based in Salt Lake City, UT, founded in 2015. It is raising on StartEngine now.
EVOQ Bio is a biotechnology company founded in 2015 and based in Salt Lake City that develops antimicrobial drug candidates for multidrug-resistant infections. The company is engineering EVQ-218, a novel antimicrobial candidate targeting pathogens associated with multidrug-resistant lung infections. Peer-reviewed research characterizes the drug's nanoscale architecture and demonstrates broad-spectrum antimicrobial activity.
Frequently asked questions about EVOQ Bio
How much funding has EVOQ Bio raised?
EVOQ Bio has raised $169.2K through crowdfunding across 1 round tracked by P2PMarketData, from 51 investors.
What is EVOQ Bio's valuation?
EVOQ Bio had an indicative valuation of $25M in its 2026 funding round.
Is EVOQ Bio profitable?
No. EVOQ Bio reported a net loss of $2K for fiscal year 2025.
How many employees does EVOQ Bio have?
EVOQ Bio reported 1 employee for fiscal year 2025.
Can I invest in EVOQ Bio?
Yes. EVOQ Bio has an open crowdfunding deal on StartEngine.
When was EVOQ Bio founded?
EVOQ Bio was founded in January 2015.
Where is EVOQ Bio based?
EVOQ Bio is headquartered in Salt Lake City, Utah, United States, and is incorporated in Delaware, United States.
What industry is EVOQ Bio in?
EVOQ Bio operates in the Biotechnology industry within the Healthcare sector.